| |
Scoring and Grading Liver Biopsies
|
Biopsy Grading and Staging |
Grading describes the
degree of inflammation and necrosis. Staging describes the degree of
fibrosis (scarring). If your doctor tells you a number to describe
your biopsy results, it is important to ask which scoring system is
used in assessing the results of the biopsy. |
| |
|
|
The Knodell
Histological Activity Index (HAI) |
Simple and popular, but
because of the way biopsy specimens
are evaluated, different laboratories can produce different results
from the same sample. |
| |
|
|
The Ishak
Modified HAI |
A modification of the
Knodell HAI system, more sensitive and accurate in assessing fibrosis.
Fibrosis staging is scored from 0 to 6, which permits physicians to
better assess the effect of therapy on fibrosis. |
| |
|
|
The METAVIR
System |
A simple system that has
been carefully evaluated and found to be accurate across large groups
of hepatitis patients. |
| |
|
|
The Scheuer
System |
A very simple method for
describing biopsy results, initially developed to rate chronic viral
hepatitis but now applied to nonviral hepatitis as well. |
| |
|
|
The Batts
and Ludwig System |
Another fairly simple system used for rating portal inflammation,
lobular inflammation and fibrosis. |
When you receive
the results of your liver biopsy, you will hear the terms inflammatory
grade and fibrotic
stage. Health care providers use these
terms to indicate the amount of injury to the liver.
There are three different methods used for scoring liver biopsies. This
can cause confusion for both patients and health care providers. Be aware
that the scoring systems are also subject to interpretation by the
pathologist who examines your biopsy.
The three scoring and grading systems for liver biopsies are the Original
HAI (Histology Activity Index), the Modified HAI, and the Metavir. There
are important things to know about how biopsies are scored in order to
understand what your score means.
- A score for a
given biopsy characteristic in one system does not mean the same
thing in the other systems.
- The scores for
all of the characteristics of the tissue sample are added
together for a final score, except as specified in the notes under the
table for that system (see below Tables 1-5).
- A final score
from one biopsy may have the same score as that of a follow-up biopsy,
but the scores for individual characteristics may have changed. This
means your situation could actually be better or worse depending on the
individual characteristic scores.
Until there is a
single biopsy scoring system, there are things you need to know and track
regarding your liver biopsy results.
- What system did
the pathologist use to grade each of your biopsies?
- If you have had
more than one biopsy, you need to look at changes in both the individual
characteristics and the overall score.
Make sure your
health care provider completely explains the results of your biopsy to
you. Ask for an explanation of the individual scores as well as the
overall score. You should be given a description of the inflammatory grade
and fibrotic stage. Ask to speak with the pathologist who evaluated your
biopsy if your health care provider is unable to provide this information.
Biopsies are invasive and therefore, you are not likely to have one done
often. For this reason, it is very important that you understand the
results of your liver biopsy so you can use this information to help you
make decisions about your health care.
The following
tables comparing the three systems used to score liver biopsies are
courtesy of David Kleiner, MD of the National Cancer Institute.
http://www.hepcchallenge.org/manual/progression_final.htm
|
Table 1.
Comparison of Scoring Systems: Periportal Necroinflammatory
Changes
|
|
Score
|
|
|
|
|
0
|
None |
Absent |
Absent |
|
1
|
Mild piecemeal necrosis |
Mild (focal, few portal areas) |
Diffuse alteration of the periportal tract in some portal tracts or
focal |
|
2
|
|
Mild/Moderate (focal, most portal areas) |
Diffuse alteration of the periportal tract in some portal tracts or
focal |
|
3
|
Moderate piecemeal necrosis (involves less than 50% of the
circumference of most portal tracts |
Moderate (continuous around <50% of tracts or septae) |
Diffuse alteration of the periportal plate in all portal tracts
|
|
4
|
Marked piecemeal necrosis (involves more than 50% of the
circumference of most portal tracts |
Severe (continuous around >50% of tracts or septae) |
|
|
[a] The Periportal component of the Knodell HAI has
been split into a Periportal piecemeal necrosis and a
bridging/confluent necrosis component for better comparison to the
other scoring systems. In order to recreate the original scale, the
bridging/confluent necrosis component should be added to the
Periportal piecemeal necrosis component. |
|
[b] The Periportal component of the METAVIR score is
used with the focal necrosis score to determine overall inflammatory
activity. |
|
Table 2.
Comparison of Scoring Systems: Bridging and Confluent Necrosis
|
|
Score
|
|
|
|
|
0
|
Absent |
Absent |
Absent |
|
1
|
|
Focal confluent necrosis |
Present |
|
2
|
Bridging necrosis (more than two such bridges) |
Zone 3 necrosis in some areas |
|
|
3
|
|
Zone 3 necrosis in most areas |
|
|
4
|
|
Zone 3 necrosis + occasional portal-central bridging necrosis |
|
|
5
|
|
Zone 3 necrosis + multiple portal-central bridging necrosis |
|
|
6
|
Multilobular necrosis |
Panacinar or multiacinar necrosis |
|
|
[a] The Periportal component of the Knodell HAI has
been split into a Periportal piecemeal necrosis and a
bridging/confluent necrosis component for better comparison to the
other scoring systems. In order to recreate the original scale, the
bridging/confluent necrosis component should be added to the
Periportal piecemeal necrosis component. |
|
[b] The METAVIR score for bridging necrosis is not used
in the overall activity determination by this system and is provided
only for comparison with other scales. |
|
Table 3.
Comparison of Scoring Systems: Focal (Spotty) Lobular Necrosis
and Hepatocellular Apoptosis
|
|
Score
|
|
|
|
|
0
|
None |
Absent |
Less than one necroinflammatory focus per lobule |
|
1
|
Mild (acidophilic
bodies, ballooning degeneration, and/or scattered foci of
hepatocellular necrosis in less than 1/3 of lobules/nodules |
One focus or less
per 10x field |
At least one
necroinflammatory focus per lobule |
|
2
|
|
Two to 4 foci per
10x field |
Several
necroinflammatory foci per lobule or confluent/bridging necrosis |
|
3
|
Moderate
(involvement of 1/3 to 2/3 of lobules/nodules) |
Five to 10 foci
per 10x field |
|
|
4
|
Marked
(involvement of more than 2/3 of lobules/nodules) |
More than 10 foci
per 10x field |
|
|
Table 4.
Comparison of Scoring Systems: Portal Inflammation
|
|
Score
|
|
|
|
|
0
|
No portal
inflammation |
None |
Absent |
|
1
|
Mild (sprinkling
of inflammatory cells in less than 1/3 of portal tracts) |
Mild, some or all
portal areas |
Presence of
mononuclear aggregates in some portal tracts |
|
2
|
|
Moderate, some or
all portal areas |
Mononuclear
aggregates in all portal tracts |
|
3
|
Moderate
(increased inflammation in 1/3 - 2/3 of portal tracts) |
Moderate/marked,
all portal areas |
Large and dense
mononuclear aggregates in all portal tracts |
|
4
|
Marked (dense
packing of inflammatory cells in more than 2/3 of portal tracts) |
Marked, all portal
areas |
|
|
[a] The METAVIR score for bridging necrosis is
not used in the overall activity determination by this system and is
provided only for comparison with other scales. |
|
Table 5.
Comparison of Scoring Systems: Fibrosis
|
|
Score
|
|
|
|
|
0
|
No fibrosis |
No fibrosis |
No fibrosis |
|
1
|
Fibrosis portal
expansion |
Fibrosis expansion
of some portal areas, with or without short fibrous septa |
Stellate
enlargement of portal tracts without septae formation |
|
2
|
|
Fibrosis expansion
of most portal areas, with or without short fibrous septa |
Enlargement of
portal tracts with rare septae formation |
|
3
|
Bridging fibrosis
(portal-portal or portal-central linkage) |
Fibrosis expansion
of most portal areas, with occasional portal to portal bridging |
Numerous septae
without fibrosis |
|
4
|
Cirrhosis |
Fibrosis expansion
of portal areas, with marked bridging (portal to portal as well as
portal to central) |
Cirrhosis |
|
5
|
|
Marked bridging
with occasional nodules (incomplete cirrhosis) |
|
|
6
|
|
Cirrhosis,
probable or definite |
|
|
[a] The METAVIR score for bridging necrosis is
not used in the overall activity determination by this system and is
provided only for comparison with other scales. |
Table 6 shows
how the HAI inflammation scores relate to the grade of histological
injury. In the HAI system, the various inflammation scores are added
together. These numbers are directly related to the descriptive grade
of inflammation.
|
Table 6.
Relationship of Aggregate Inflammation Scores to grade of Activity
|
|
Sum of inflammation scores in HAI or modified
HAI systems
|
Description of activity
|
|
0 |
None
|
|
1-4 |
Minimal
|
|
5-8 |
Mild
|
|
9-12 |
Moderate
|
|
13-18 |
Marked
|
Grade and Stage :
Inflammation
Portal:
Grade 0 no inflammation
Grade 1 peri-portal inflammation no hepatocellular necrosis
Grade 2 inflammation with mild interface hepatitis
Grade 3 severe portal inflammation with moderate interface hepatitis
Grade 4 marked inflammation with severe interface hepatitis
Lobular:
Grade 0 no inflammation
Grade 1 minimal, no necrosis (inflammatory cells within the lobule)
Grade 2 moderate inflammatory cells with occasional liver cell necrosis
Grade 3 marked inflammation with severe focal liver cell necrosis
Grade 4 extensive inflammation with bridging necrosis
Fibrosis:
Stage 1 none or mild peri-portal fibrosis
Stage 2 peri-portal fibrosis with/without extension and portal-portal
bridging
Stage 3 portal-central bridges but no nodular formation
Stage 4 probable or definite cirrhosis
Definitions:
Necrosis One of the two
mechanisms by which cell death occurs (the other being the physiological
process of apoptosis. Necrosis is caused by the progressive degradative
action of enzymes and is generally associated with severe cellular trauma.
It is characterized by mitochondrial swelling, nuclear flocculation, and
uncontrolled cell lysis. Decay or death of one or more cells, resulting from
irreversible damage. Death of living tissue; death of a portion of tissue
differentially affected by local injury (as loss of blood supply,burning,
corrosion, or the local lesion of a disease)
Portal Communicating part or
area of an organism, such as Portal Vein. The point at which something
enters the body. Of or relating to the Porta Hepatis
Fibrosis
Scar formation resulting from the repair of tissue damage. If it occurs
extensively in the liver, it is called cirrhosis, Formation of fibrous
tissue; fibroid or fibrous degeneration. Condition marked by increase
of interstitial fibrous tissue, fibrous degeneration
Bridging Fibrosis When scarring
from portal cell to portal cell occurs. Fibrous tissue extends from the
portal cells. In early bridging the finger like protrusions of scar tissue
do not extend completely from one portal cell to the next.
Grading system for cirrhosis:
the Child-Pugh score
| Score |
Bilirubin
(mg/dl) |
Albumin
(gm/dl) |
PT (Sec) |
Hepatic
encephal |
Ascites
(grade) |
| 1 |
< 2 |
> 3.5 |
1 - 4 |
None |
None |
| 2 |
2 - 3 |
2.8 - 3.5 |
4 - 6 |
1 - 2 |
Mild |
| 3 |
> 3 |
< 2.8 |
> 6 |
3 - 4 |
Severe |
Child class: A= 5 - 6, B= 7 - 9, C= > 9
Staging Cirrhosis
Hepatitis has 4 stages. Stage 4 Hepatitis = Cirrhosis.
Then,
There's 3 stages to Cirrhosis:
Stage A ("compensated"; not too sick)
Stage B (beginning to decompensate; complications beginning to appear)
Stage C ("decompensated"; end stage)
Doctors use something called a CTP Score, to see what Stage of cirrhosis
that a person is in.
The CTP Score is based on FIVE QUESTIONS.
You receive a point value (score) for each of the answers.
Here's how it works:
1. Total Serum Bilirubin
.....if Bilirubin is <2 mg/dl: score 1 point
.....if Bilirubin is 2-3 mg/dl: score 2 points
.....if Bilirubin is >3 mg/dl: score 3 points
2. Serum Albumin
.....if Albumin is >3.5 g/dl: score 1 point
.....if Albumin is 2.8 to 3.5 g/dl: score 2 points
.....if Albumin is <2.8 g/dl: score 3 points
3. INR
.....if INR is <1.70: score 1 point
.....if INR is 1.71 to 2.20: score 2 points
.....if INR is >2.20: score 3 points
4. Ascites
.....No Ascites: score 1 point
.....Ascites controlled medically: score 2 points
.....Ascites poorly controlled: score 3 points
5. Encephalopathy
.....No Encephalopathy: score 1 point
.....Encephalopathy controlled medically: score 2 points
.....Encephalopathy poorly controlled: score 3 points
Total your score.
Sum total score gives grades of:
5 to 6 points = Stage A Cirrhosis
7 to 9 points = Stage B Cirrhosis
10 to 15 points = Stage C Cirrhosis
A person has to be at least Stage B or Stage C, in order to get
referred for an "Evaluation" for a chance at the liver transplant waiting
list. (Stage A Cirrhosis is not sick enough to think about a referral for
an evaluation).
iCTP scores and MELD scores are two completely different things.
MELD scores are use for allocation of donor livers
PS- There's more examples of these scorecards at
112.1 (you can scroll
through about a dozen of them there)
Thank you Imkindly, please visit her wonderful support forum :
|